RNA molecules are masters of their own destiny

Research suggests the products of transcription — RNA molecules — regulate their own production through a feedback loop.

Eva Frederick | Whitehead Institute • mit
Jan. 5, 2021 ~8 min

physics chemistry genetics biology rna research drug-development school-of-engineering school-of-science whitehead-institute chemical-engineering

Turning microbiome research into a force for health

A diverse group of researchers is working to turn new discoveries about the trillions of microbes in the body into treatments for a range of diseases.

Zach Winn | MIT News Office • mit
Jan. 5, 2021 ~10 min

health medicine bacteria startups broad-institute microbes disease research drug-development school-of-engineering innovation-and-entrepreneurship-ie alumniae biological-engineering


Small molecule, big potential for treating prostate cancer

MIT researchers identify a molecule that could target advanced prostate cancer as well as a variety of other cancers.

Bendta Schroeder | Koch Institute • mit
Nov. 19, 2020 ~9 min

medicine cancer research drug-development school-of-engineering national-institutes-of-health-nih biological-engineering koch-institute

Silencing gene expression to cure complex diseases

Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.

Zach Winn | MIT News Office • mit
Oct. 26, 2020 ~9 min

health medicine genetics cancer startups biology rna alzheimers data disease research drug-development school-of-engineering innovation-and-entrepreneurship-ie alumniae biological-engineering



Finch Therapeutics unleashes the power of the gut

The company is developing treatments that restore gut bacteria in people struggling with a range of diseases.

Zach Winn | MIT News Office • mit
July 23, 2020 ~8 min

health medicine bacteria startups microbes microbiology research drug-development school-of-engineering alumniae biological-engineering microboime

How cancer drugs find their targets

Certain cancer therapeutics concentrate within cells — a finding that could change the way scientists think about drug design.

Eva Frederick | Whitehead Institute • mit
June 26, 2020 ~10 min

medicine cancer biology research drug-development school-of-science whitehead-institute koch-institute drug-delivery

Experimental peptide targets Covid-19

Computational modeling yields a protein fragment that could bind to coronavirus spike proteins and destroy them.

Anne Trafton | MIT News Office • mit
June 22, 2020 ~6 min

covid-19 pandemic research drug-development media-lab school-of-architecture-and-planning biological-engineering

/

8